DANIEL YEE: Open Payments
NPI 1619414430 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 11 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $146 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| ARRAY BIOPHARMA INC | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
Products named: Enhertu, LORBRENA, Onivyde, ZYNLONTA, FRUZAQLA, ENJAYMO, Flexitouch Plus, ELREXFIO.
Industry payments across CA — which companies pay providers there.
